Diebold Nixdorf, Incorporated
General ticker "DBD" information:
- Sector: Information Technology
- Industry: Software - Application
- Capitalization: $1.9B (TTM average)
Diebold Nixdorf, Incorporated follows the US Stock Market performance with the rate: 70.8%.
Estimated limits based on current volatility of 1.6%: low 77.84$, high 80.33$
Factors to consider:
- Total employees count: 21000 (0.0%) as of 2024
- US accounted for 25.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Currency fluctuations, Supply chain disruptions, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [59.47$, 86.24$]
- 2026-12-31 to 2027-12-31 estimated range: [60.53$, 88.66$]
Financial Metrics affecting the DBD estimates:
- Negative: with PPE of 14.2 at the end of fiscal year the price was high
- Positive: -4.75 < Operating profit margin, % of 6.36
- Positive: 6.64 < Operating cash flow per share per price, % of 11.97
- Positive: Industry inventory ratio change (median), % of 0.07 <= 0.31
- Positive: 19.40 < Shareholder equity ratio, % of 28.54 <= 42.68
- Positive: Inventory ratio change, % of -0.36 <= 0
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.47
- Positive: -4.43 < Investing cash flow per share per price, % of -3.88
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 1.37
Short-term DBD quotes
Long-term DBD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,760.50MM | $3,750.40MM | $3,805.70MM |
| Operating Expenses | $3,673.60MM | $3,568.30MM | $3,563.70MM |
| Operating Income | $86.90MM | $182.10MM | $242.00MM |
| Non-Operating Income | $1,365.40MM | $-134.80MM | $-120.40MM |
| Interest Expense | $246.20MM | $155.30MM | $85.70MM |
| R&D Expense | $110.90MM | $93.60MM | $86.70MM |
| Income(Loss) | $1,452.30MM | $47.30MM | $121.60MM |
| Taxes | $75.70MM | $64.30MM | $24.10MM |
| Other Income(Loss) | $0.00MM | $2.50MM | $0.00MM |
| Profit(Loss)* | $1,376.10MM | $-16.50MM | $94.60MM |
| Stockholders Equity | $1,063.80MM | $929.80MM | $1,099.90MM |
| Inventory | $589.80MM | $528.10MM | $521.00MM |
| Assets | $4,162.00MM | $3,543.50MM | $3,854.40MM |
| Operating Cash Flow | $-257.00MM | $149.20MM | $300.70MM |
| Capital expenditure | $24.90MM | $17.40MM | $37.40MM |
| Investing Cash Flow | $-36.10MM | $-45.50MM | $-97.60MM |
| Financing Cash Flow | $559.50MM | $-366.50MM | $-143.90MM |
| Earnings Per Share** | $21.38 | $-0.44 | $2.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.